Add BrightSurf on Google Email

Plant-derived anti-inflammatory compounds: Bridging the translation gap from molecular targets to therapeutic candidates

The review proposes an evidence framework to separate direct target engagement from downstream effects in plant-derived anti-inflammatory drug discovery. Plant-derived compounds exhibit pleiotropy, influencing multiple inflammatory pathways, but direct target binding and downstream effects are distinct.

SourceImmunity & Inflammation·JournalImmunity & Inflammation·TypeSystematic review·DateNov 5, 2026

Inflammation is already elevated at the earliest stage of cardiovascular-kidney-metabolic syndrome

A new analysis of US national health data found that inflammation increases across the stages of cardiovascular-kidney-metabolic syndrome, with the largest increase at the earliest stage. Average hs-CRP nearly doubled between stage 0 and stage 1, crossing the 2 mg/L threshold commonly used to signal increased cardiovascular risk.

SourceUniversity of Eastern Finland·JournalEuropean Journal of Preventive Cardiology·DateOct 14, 2026

Body clock found to control inflammatory responses in macrophages

Researchers from Kyushu University discovered that the circadian clock protein BMAL1 drives macrophages towards a pro-inflammatory M1 state by activating inflammatory signaling pathways. This mechanism links the body clock to intracellular metabolism and immune function, offering new insights into treating inflammatory diseases.

SourceKyushu University·JournalCell Reports·TypeExperimental study·DateJun 11, 2026

Research spotlight: A subset of patients with depression could benefit from anti-inflammatory treatment

A subset of depressed individuals with chronic, low-grade inflammation may benefit from anti-inflammatory treatment, according to a systematic review and meta-analysis. The study found that anti-inflammatory medications significantly reduced depressive symptom severity and anhedonia in these patients.

SourceBrigham and Women's Hospital·JournalAmerican Journal of Psychiatry·TypeSystematic review·DateDec 10, 2025

Lower prevalence of PSC among patients with IBD in Asia: Insights from a multinational study

A multinational study found PSC prevalence among Asian IBD patients to be markedly lower than in Western countries, associated with more favorable clinical outcomes. The proportion of asymptomatic PSC cases has increased due to improved imaging modality detection, allowing for early-stage diagnosis and reduced liver transplantation rates.

SourceUniversity of Tsukuba·JournalClinical Gastroenterology and Hepatology·DateDec 2, 2025

University of Minnesota research finds reducing inflammation may protect against early AMD-like vision loss

University of Minnesota researchers found that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical models. The strategy aims to intervene before severe damage occurs, potentially delaying or preventing vision loss for those with early signs of AMD.

SourceUniversity of Minnesota Medical School·JournalCell Death and Disease·TypeRandomized controlled/clinical trial·DateNov 21, 2025

Chemists design candidate drug against diabetes

A new small molecule drug, RAGE406R, has been developed to disrupt a key cellular pathway responsible for chronic inflammation and associated complications in patients with diabetes. The breakthrough could offer a new therapeutic option for stopping the harmful effects of both type 1 and type 2 diabetes at the source.

SourceUniversity at Albany, SUNY·JournalCell Chemical Biology·TypeExperimental study·DateOct 29, 2025

The link between immune aging and type 2 diabetes

This review synthesizes evidence highlighting immune aging as a critical accelerator of type 2 diabetes pathogenesis. Chronic low-grade inflammation, organelle stress pathways, and the ominous octet framework contribute to metabolic-inflammatory vortex, disrupting β-cell function and insulin signaling.

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateAug 6, 2025

A Journal of Intensive Medicine editorial highlights a new metabolic checkpoint in immunity

Researchers discover a novel metabolic pathway, glyoxalase system, that regulates excessive immune responses by targeting a previously underexplored metabolic pathway. The GLO2-SLG-D-lactylation pathway suppresses inflammatory signaling, reducing inflammation in acute and autoimmune disease settings.

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeCommentary/editorial·DateJul 7, 2025

Virtual pulmonary rehabilitation programs are safe, effective for people with COPD

A new report published in the COPD Foundation's journal found virtual pulmonary rehabilitation to be a safe and effective alternative for people with COPD who require supplemental oxygen. The program improved clinical outcomes and quality of life for participants, demonstrating its potential to increase access to care.

SourceCOPD Foundation·JournalChronic Obstructive Pulmonary Diseases Journal of the COPD Foundation·DateMay 1, 2025

Feeling stressed may lead to worsened respiratory symptoms, decreased quality of life

A new study found that increased perceived stress can lead to worsened respiratory symptoms and decreased quality of life in individuals with chronic obstructive pulmonary disease (COPD). The study also examined the association between stress and platelet activation, oxidative stress, and systemic inflammation.

SourceCOPD Foundation·JournalChronic Obstructive Pulmonary Diseases Journal of the COPD Foundation·TypeObservational study·DateApr 29, 2025

Unhealthy metabolic profile sharply increases risk of breast cancer returning and subsequent death from breast cancer among those who have survived the disease

A new study published in The Journal of Internal Medicine found that having an unhealthy metabolic profile increases the risk of breast cancer recurrence by 69% and subsequent breast cancer mortality by 83% among survivors. This association was consistent across Europe, North America, and Asia.

SourceEuropean Association for the Study of Obesity·JournalJournal of Internal Medicine·DateApr 16, 2025

Protein in the nose provides information about COPD

Researchers at Karolinska Institutet have developed a new method to diagnose COPD by analyzing protein levels in nasal lavage. The study found that elevated IL-26 levels can indicate an early phase of the disease, and may lead to new treatment strategies targeting this cytokine.

SourceKarolinska Institutet·JournalJournal of Allergy and Clinical Immunology·TypeExperimental study·DateMar 28, 2025